ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 238 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2013. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $581,366 | +11.1% | 44,244 | +6.5% | 0.01% | +25.0% |
Q2 2023 | $523,252 | +172.7% | 41,528 | +182.4% | 0.00% | +100.0% |
Q1 2023 | $191,900 | -32.1% | 14,705 | -8.2% | 0.00% | 0.0% |
Q4 2022 | $282,522 | +9.5% | 16,016 | +15.0% | 0.00% | 0.0% |
Q2 2021 | $258,000 | +12.2% | 13,922 | -9.1% | 0.00% | 0.0% |
Q1 2021 | $230,000 | -42.4% | 15,314 | -44.6% | 0.00% | -33.3% |
Q4 2020 | $399,000 | -51.7% | 27,635 | -52.3% | 0.00% | -40.0% |
Q3 2018 | $826,000 | +8.8% | 57,987 | -8.1% | 0.01% | 0.0% |
Q2 2018 | $759,000 | -11.7% | 63,113 | -9.3% | 0.01% | +150.0% |
Q1 2018 | $860,000 | -5.9% | 69,606 | +11.0% | 0.00% | 0.0% |
Q4 2017 | $914,000 | -23.2% | 62,704 | -25.1% | 0.00% | -33.3% |
Q3 2017 | $1,190,000 | +22.2% | 83,663 | +9.6% | 0.00% | 0.0% |
Q2 2017 | $974,000 | +27.5% | 76,345 | +26.9% | 0.00% | +50.0% |
Q1 2017 | $764,000 | -50.0% | 60,182 | -59.8% | 0.00% | -50.0% |
Q4 2016 | $1,529,000 | -19.1% | 149,708 | +4.4% | 0.00% | -33.3% |
Q3 2016 | $1,889,000 | +35.9% | 143,407 | +31.0% | 0.01% | +50.0% |
Q2 2016 | $1,390,000 | +37.1% | 109,436 | +42.6% | 0.00% | +33.3% |
Q1 2016 | $1,014,000 | -20.0% | 76,741 | -6.9% | 0.00% | -25.0% |
Q4 2015 | $1,268,000 | +34.0% | 82,414 | +8.0% | 0.00% | +33.3% |
Q3 2015 | $946,000 | -37.3% | 76,303 | -30.8% | 0.00% | -25.0% |
Q2 2015 | $1,509,000 | +17.9% | 110,281 | +3.1% | 0.00% | +33.3% |
Q1 2015 | $1,280,000 | -94.1% | 107,010 | -93.7% | 0.00% | -94.4% |
Q4 2014 | $21,556,000 | -12.0% | 1,688,017 | -7.6% | 0.05% | -8.5% |
Q3 2014 | $24,509,000 | +836.9% | 1,826,954 | +1021.1% | 0.06% | +742.9% |
Q2 2014 | $2,616,000 | +158.0% | 162,965 | +189.9% | 0.01% | +133.3% |
Q1 2014 | $1,014,000 | +24.1% | 56,219 | +6.3% | 0.00% | +50.0% |
Q4 2013 | $817,000 | +266.4% | 52,876 | +253.0% | 0.00% | +100.0% |
Q3 2013 | $223,000 | -80.0% | 14,977 | -82.6% | 0.00% | -80.0% |
Q2 2013 | $1,116,000 | – | 86,292 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |